CSL Limited (OTCMKTS:CSLLY - Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 500 shares, a growth of 25.0% from the September 30th total of 400 shares. Based on an average daily volume of 38,300 shares, the short-interest ratio is currently 0.0 days.
CSL Stock Performance
Shares of CSL stock traded down $0.94 during trading on Monday, hitting $96.41. 22,911 shares of the stock traded hands, compared to its average volume of 29,269. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.97 and a current ratio of 2.18. The stock's fifty day simple moving average is $100.85 and its 200 day simple moving average is $97.91. CSL has a 52-week low of $71.51 and a 52-week high of $109.00.
Analyst Ratings Changes
Separately, Macquarie upgraded CSL to a "strong-buy" rating in a report on Tuesday, August 13th.
Check Out Our Latest Stock Report on CSLLY
About CSL
(
Get Free Report)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CSL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CSL wasn't on the list.
While CSL currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
